Warning: There are an increasing number of fraudulent websites that impersonate ECCMID. We would like to alert all our members and delegates to possible scams and we strongly advise you to use only the official ECCMID online registration for your bookings.

Industry Sessions


16:15 – 18:15

Menarini

Superbugs, Susceptibility & Stewardship: with more antibiotics available for MDR-GN bacterial infections, what's holding us back?


16:15 – 18:15

AstraZeneca

Deciphering the data: clinical impact of vaccines and monoclonal antibodies for COVID-19


16:15 – 18:15

Sanofi Pasteur

Importance of influenza vaccination in the COVID-19 environment


08:30 – 10:30

Seegene Inc.

An innovative approach to infection control


08:30 – 10:30

Sanofi Pasteur

Surviving invasive meningococcal disease (IMD): the long-term impact and future preventive perspectives


13:15 – 15:15

Qiagen

Syndromic diagnostics: better timing and better insights to improve patient care in COVID-19 and beyond


13:15 – 15:15

Shionogi & Co., Ltd

Taking a look inside the Trojan Horse


13:15 – 15:15

F2G Ltd.

Are we ready for personalised medicine in the treatment of mould infections?


13:15 – 15:15

Correvio International (an ADVANZ PHARMA company)

Place in therapy of contemporary lipoglycopeptides and cephalosporins in an evolving environment


16:15 – 18:15

Bruker

Changing microbiology: enhancing technologies to address today’s critical diseases


16:15 – 18:15

Gilead Sciences

The role and timing on antiviral therapy in the treatment of COVID-19


16:15 – 18:15

Qiagen

Enabling critical testing needs in clinical microbiology: innovative, random-access molecular diagnostic solutions to address pandemic and post- pandemic needs


08:30 – 10:30

Menarini

Easing patient management and improving patient outcomes with innovative molecules


13:15 – 15:15

Gilead Sciences

New frontiers in invasive fungal diseases


16:15 – 18:15

Accelerate Diagnostics Inc.

Bacteremia diagnostics in a brave new viral world: clinical microbiology and patient management considerations


07:30 – 08:30

T2 Biosystems Inc.

The crucial role of rapid diagnostics in the early detection of secondary infections and aiding in the prevention of complications related to COVID-19